Crosstalk Between DNA Methylation and Gene Mutations in Colorectal Cancer

Maria Dobre1, Alessandro Salvi2, Iulia Andreea Pelisenco3

  • 1Laboratory of Histopathology and Immunohistochemistry, Victor Babes National Institute of Pathology, Bucharest, Romania.

Frontiers in Oncology
|July 19, 2021
PubMed

Insights

Colorectal cancer (CRC) involves gene mutations and DNA methylation. This study identified nine genes with altered methylation in CRC tumors and found specific methylation patterns linked to BRAF mutations, suggesting potential biomarkers for personalized treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Colorectal cancer (CRC) pathogenesis involves genetic mutations (e.g., KRAS, BRAF) and epigenetic alterations like DNA methylation.
  • Aberrant DNA methylation in tumor suppressor and proto-oncogene promoters is a hallmark of CRC.
  • Understanding these molecular changes is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate DNA methylation profiles in colorectal cancer tissues.
  • To correlate methylation patterns with KRAS and BRAF mutation status in CRC patients.
  • To identify potential epigenetic biomarkers for CRC sub-classification and personalized treatment.

Main Methods:

  • DNA methylation levels of 22 candidate genes were analyzed in tumoral, adjacent normal, and control colon tissues.
  • KRAS and BRAF mutations were assessed in 18 CRC patient samples.
  • Methylation profiles were compared between different tissue types and mutation statuses.

Main Results:

  • A distinct methylation profile of nine genes was identified in CRC tumoral tissues compared to normal tissues.
  • KRAS mutations were found in 40% and BRAF mutations in 22% of the evaluated CRC cases.
  • Six genes (SFRP2, DKK2, PCDH10, TMEFF2, SFRP1, HS3ST2) exhibited higher methylation in BRAF-mutated CRC cases.

Conclusions:

  • Epigenetic modifications, specifically DNA methylation, play a significant role in colorectal cancer development.
  • Specific gene methylation patterns are associated with KRAS and BRAF mutations in CRC.
  • Molecular sub-classification based on mutations and epigenetic alterations can aid in identifying biomarkers for personalized CRC management.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.3K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.7K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.5K
Mismatch Repair01:36

Mismatch Repair

Overview
41.3K
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
366
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.3K